What is Pralatrexate: Uses, Dosage, Side Effects and More

Pralatrexate is a specialized chemotherapy medication given through an IV to treat certain types of blood cancers. It's designed to target and slow down cancer cells that have become resistant to other treatments, offering hope when other options may not be working as well.

This medication belongs to a class called antifolate drugs, which work by interfering with how cancer cells use folate (a type of B vitamin) to grow and multiply. Think of it as disrupting the cancer cells' ability to make the building blocks they need to survive and spread.

What is Pralatrexate?

Pralatrexate is a targeted chemotherapy drug that blocks cancer cells from using folate, an essential nutrient they need to grow. It's specifically designed to work against certain blood cancers that have developed resistance to other folate-blocking medications.

The medication is given only in healthcare settings through an IV infusion, which allows doctors to monitor you closely during treatment. This careful approach helps ensure you receive the right dose while managing any side effects that might occur.

What is Pralatrexate Used For?

Pralatrexate is primarily used to treat peripheral T-cell lymphoma (PTCL), a rare type of blood cancer that affects your immune system. It's typically prescribed when other treatments haven't worked well enough or when the cancer has returned after previous therapy.

Your doctor might recommend this medication if you have relapsed or refractory PTCL, meaning your cancer either came back after treatment or didn't respond well to initial therapies. While this can feel overwhelming, pralatrexate offers another treatment option specifically designed for these challenging situations.

How Does Pralatrexate Work?

Pralatrexate works by blocking an enzyme called dihydrofolate reductase, which cancer cells need to process folate and make DNA. Without this process working properly, cancer cells can't reproduce and eventually die.

This medication is considered a strong, targeted therapy that's more potent than some older folate-blocking drugs. It's been specially engineered to get inside cancer cells more effectively, which is why it can work even when other similar medications haven't been successful.

The drug circulates through your bloodstream and specifically targets rapidly dividing cells, which include cancer cells. While it can affect some healthy cells too, the goal is to hit the cancer cells harder than your normal, healthy tissues.

How Should I Take Pralatrexate?

Pralatrexate is always given by healthcare professionals through an IV line in a hospital or infusion center. You'll receive it as an infusion over about 3-5 minutes, typically once a week for six weeks, followed by a one-week break.

Before each infusion, you'll need to take folic acid and vitamin B12 supplements to help protect your healthy cells from the medication's effects. Your healthcare team will give you specific instructions about when and how to take these supplements - this is an important part of your treatment plan.

You don't need to fast before your infusion, but eating a light meal beforehand might help you feel more comfortable during treatment. Some people find it helpful to bring snacks and water to stay hydrated during their visit.

How Long Should I Take Pralatrexate For?

The length of your pralatrexate treatment depends on how well your cancer responds and how you're tolerating the medication. Most people continue treatment as long as it's working and the side effects remain manageable.

Your doctor will regularly monitor your progress through blood tests, scans, and physical exams to determine if the treatment is helping. Some people may receive several cycles of treatment, while others might need to adjust their plan based on how they're responding.

The decision to continue or stop treatment is always made together with your healthcare team, taking into account both the benefits you're seeing and any side effects you're experiencing.

What Are the Side Effects of Pralatrexate?

Like most chemotherapy medications, pralatrexate can cause side effects, though everyone's experience is different. The most common side effects are generally manageable with proper medical support and monitoring.

Here are the side effects you might experience, and it's important to remember that your healthcare team is prepared to help you manage any of these:

• Low blood cell counts: This can make you more prone to infections, bruising, or feeling tired
• Mouth sores: These can be uncomfortable but usually heal between treatment cycles
• Nausea and vomiting: Anti-nausea medications can help significantly with these symptoms
• Fatigue: This is very common and tends to improve between treatment cycles
• Skin reactions: You might notice rashes or changes in skin color
• Loss of appetite: Working with a nutritionist can help maintain proper nutrition

Less common but more serious side effects can include severe infections due to low white blood cell counts, or liver problems that show up in blood tests. Your medical team monitors for these closely through regular lab work.

Some rare but serious side effects include severe skin reactions, lung problems, or kidney issues. While these are uncommon, it's important to contact your healthcare team immediately if you develop fever, difficulty breathing, or any concerning symptoms between treatments.

Who Should Not Take Pralatrexate?

Pralatrexate isn't suitable for everyone, and your doctor will carefully review your medical history before recommending this treatment. People with certain conditions may need different treatment options or special monitoring.

You should discuss alternatives with your doctor if you have any of these conditions:

• Severe kidney problems: The medication is processed through your kidneys
• Active serious infections: The drug can lower your immune system's ability to fight infections
• Severe liver disease: This can affect how your body processes the medication
• Pregnancy or breastfeeding: The medication can harm developing babies
• Severe heart problems: Some people may need cardiac monitoring during treatment

Your healthcare team will also consider your overall health status, other medications you're taking, and previous reactions to similar treatments when determining if pralatrexate is right for you.

Pralatrexate Brand Name

Pralatrexate is sold under the brand name Folotyn in the United States. This is the only brand name currently available for this medication.

Since this is a specialized cancer medication, it's only available through specific healthcare facilities and specialty pharmacies that work with oncology treatments. Your cancer center will coordinate getting this medication for your treatment.

Pralatrexate Alternatives

If pralatrexate isn't suitable for you or stops working effectively, several other treatment options exist for peripheral T-cell lymphoma. The choice depends on your specific situation and medical history.

Alternative treatments might include other chemotherapy combinations, targeted therapy drugs like romidepsin or belinostat, or immunotherapy approaches. Some people might also be candidates for stem cell transplantation if they're in good enough health.

Your oncologist will discuss these options with you based on your cancer's characteristics, your previous treatments, and your overall health status. Each option has its own benefits and considerations.

Is Pralatrexate Better Than Methotrexate?

Pralatrexate and methotrexate are both folate-blocking medications, but they work differently and are used for different conditions. Pralatrexate is specifically designed for blood cancers that have become resistant to other treatments, including methotrexate.

For peripheral T-cell lymphoma, pralatrexate is often more effective because it's been engineered to get into cancer cells more easily than methotrexate. This makes it particularly useful when other folate-blocking drugs haven't worked well.

However, methotrexate is used for many different conditions and is generally considered first-line treatment for various cancers and autoimmune diseases. The choice between them depends entirely on your specific diagnosis and treatment history.